AHA Names Five Finalists for 2026 Health Tech Competition
The five companies will pitch their technologies at Scientific Sessions 2026 in Chicago, with winners announced Nov. 8.
Updated on Nov. 12, 2026 in Heart Disease

The American Heart Association has selected five finalists for its 2026 Health Tech Competition from a record number of submissions by health technology companies worldwide. The finalists were chosen through a multi-stage review by AHA volunteer experts.
Why it matters
Promising health technologies often face significant barriers to adoption, which limits their impact on patients and clinicians. The competition is designed to spotlight innovations that could address heart and vascular care.
The competition drew a record number of submissions, and five finalists were picked after review by AHA volunteer experts. Finalist evaluation criteria include clinical evidence, scientific innovation and market need, and the winners remain to be determined.
The players
American Heart Association
The American Heart Association is a leading nonprofit organization focused on cardiovascular health and research, supported by volunteers worldwide.
HEARTio
HEARTio is a company developing investigational AI software for detecting coronary artery disease from standard electrocardiograms.
MedRhythms
MedRhythms is a company that uses music-based sensor and software therapy to help patients regain walking and mobility.
The details
The finalists include HEARTio, developing AI software that estimates obstructive coronary artery disease from a standard ECG; MEGI, an AI digital health platform for women's heart health; MedRhythms, which pairs sensors, software and music to improve mobility after neurological injury; Seerlinq, which estimates cardiac filling pressure from a fingertip measurement; and Vascudyne, which develops bioengineered blood vessels. Each finalist will present in the Health Innovation Pavilion during Scientific Sessions 2026.
Timeline
Nov. 6-9, 2026: Scientific Sessions 2026 at McCormick Place in Chicago
Nov. 7-8, 2026: Finalist competition pitches
Nov. 8, 2026: Winners announced
Big Picture
The 2026 competition continues the AHA's tradition of showcasing emerging cardiovascular technologies at its annual Scientific Sessions meeting in Chicago. The finalists span AI diagnostics, digital therapeutics and bioengineered tissue, reflecting the breadth of heart-health innovation.
New cardiovascular technologies such as AI-assisted ECG screening and at-home fingertip measurements could expand how heart conditions are detected outside specialist settings. Readers should watch for winners and any subsequent regulatory or clinical availability.
The takeaway
Emerging heart-health tools are increasingly built on AI and remote monitoring, so patients may soon have more options for early detection. Keep an eye on which finalists move from competition to clinical use.
What happens next
Winners of the 2026 Health Tech Competition will be announced Nov. 8 during Scientific Sessions 2026 in Chicago.
Further reading
Explore more on heart disease and the emerging tools being developed to address it.
More information
Find the full list of Health Tech Competition finalists and event details on the American Heart Association's competition page.
Source note: This article includes information reported by American Heart Association.






